Publication | Closed Access

Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab

MedicineImmunologyPathologyColorectal CancerImmune Checkpoint InhibitorNeutrophil/lymphocyte RatioCancer TreatmentAlbumin LevelsOncologyRadiation OncologyPlatelet Count